Influence of hemodilution of plasma proteins on erythrocyte aggregability: An in vivo study in patients undergoing cardiopulmonary bypass

Clinical Hemorheology and Microcirculation

Volumn 33, Issue 2, 2005, Pages 95-107

  Gu, Y J ^a   Graaff, R ^a   De Hoog, E ^a   Veeger, N J G M ^a   Panday, G ^a   Boonstra, P W ^a   Van Oeveren, W ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Albumin; C reactive protein; Ceruloplasmin; Erythrocyte aggregation; Erythrocyte deformability; Fibrinogen; Haptoglobin

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CERULOPLASMIN; FIBRINOGEN; HAPTOGLOBIN; PLASMA PROTEIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FIBRINOGEN BLOOD LEVEL; HEART SURGERY; HEMATOCRIT; HEMODILUTION; HUMAN; MEDICAL INSTRUMENTATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL;

ACUTE-PHASE PROTEINS; AGED; BLOOD PROTEINS; CARDIOPULMONARY BYPASS; ERYTHROCYTE AGGREGATION; HEMATOLOGIC TESTS; HEMODILUTION; HUMANS; MIDDLE AGED; TIME FACTORS;

EID: 24344436714     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. J.K. Kirklin, Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass, Ann. Thorac. Surg. 51 (1991), 529-531.
2. L.H. Edmunds Jr., Blood-surface interactions during cardiopulmonary bypass, J. Card. Surg. 8 (1993), 404-410.
3. W. van Oeveren, Leukocyte and platelet activation during extracorporeal circulation, Cells Materials 4 (1994), 187-195.
4. M. Benedetti, R. De Caterina, A. Bionda et al., Blood-artificial surface interactions during cardiopulmonary bypass. A comparative study of four oxygenators, Int. J. Artif. Organs 13 (1990), 488-497.
5. Y.J. Gu, P.W. Boonstra, R. Graaff, A.A. Rijnsburger, H. Mungroop and W. van Oeveren, Pressure drop, shear stress, and activation of leukocytes during cardiopulmonary bypass: a comparison between hollow fiber and flat sheet membrane oxygenators, Artif. Organs 24 (2000), 43-48.
6. P.R. Hickey, M.J. Buckley and D.M. Philbin, Pulsatile and nonpulsatile cardiopulmonary bypass: review of a counterproductive controversy, Ann. Thorac. Surg. 36 (1983), 720-737.
7. J.D. Milam, S.F. Austin, R.F. Martin, A.S. Keats and D.A. Cooley, Alteration of coagulation and selected clinical chemistry parameters in patients undergoing open heart surgery without transfusions, Am. J. Clin. Pathol. 76 (1981), 155-162.
8. R. Martin, S. McKenty, Y. Thisdale et al., Hemolysis during cardiopulmonary bypass, J. Cardiothorac. Anesth. 3 (1989), 737-740.
9. R.M. Lohrer, A.R. Trammer, W. Dietrich, S. Hagl and O. Linderkamp, The influence of extracorporeal circulation and hemoseparation on red cell deformability and membrane proteins in coronary artery disease, J. Thorac. Cardiovasc. Surg. 99 (1990), 735-740.
10. M.V. Kameneva, A. Undar, J.F. Antaki, M.J. Watach, J.H. Calhoon and H.S. Borovetz, Decrease in red blood cell deformability caused by hypothermia, hemodilution, and mechanical stress: factors related to cardiopulmonary bypass, ASAIO J. 45 (1999), 307-310.
11. L. Dintenfass, Influence of plasma proteins on the in vivo and in vitro rheological properties of blood, Clin. Hemorheol. 5 (1985), 191-206.
12. A.L. Copley, On erythrocyte aggregation and disaggregation, Clin. Hemorheol. 7 (1987), 3-14.
13. X. Weng, G. Cloutier, R. Beaulieu and G.O. Roederer, Influence of acute-phase proteins on erythrocyte aggregation, Am. J. Physiol. Heart. Circ. Physiol. 271 (1996), H2346-2352.
14. L.H. Deng, J.C. Barbenel and G.D. Lowe, Influence of hematocrit on erythrocyte aggregation kinetics for suspensions of red blood cells in autologous plasma, Biorheology 31 (1994), 193-205.
15. X. Weng, G. Cloutier, P. Pibarot and L.G. Durand, Comparison and simulation of different levels of erythrocyte aggregation with pig, horse, sheep, calf, and normal human blood, Biorheology 33 (1996), 365-377.
16. N. Maeda, M. Seike, S. Kume, T. Takaku and T. Shiga, Fibrinogen-induced erythrocyte aggregation: erythrocyte-binding site in the fibrinogen molecule, Biochim. Biophys. Acta 904 (1987), 81-91.
17. Z. Marton, G. Kesmarky, J. Vekasi, A. Cser, R. Russai, B. Horvath and K. Toth, Red blood cell aggregation measurements in whole blood and in fibrinogen solutions by different methods, Clin. Hemorheol. Microcirc. 24 (2001), 75-83.
18. D. Lominadze and W.L. Dean, Involvement of fibrinogen specific binding in erythrocyte aggregation, FEBS. Lett. 517 (2002), 41-44.
19. Y.J. Gu, M.A. Mariani, P.W. Boonstra, J.G. Grandjean and W. van Oeveren, Complement activation in coronary artery bypass grafting patients without cardiopulmonary bypass: the role of tissue injury by surgical incision, Chest 116 (1999), 892-898.
20. M.R. Hardeman, P.T. Goedhart, J.G.G. Dobbe and K.P. Lettinaga, Laser-assist optical rotational cell analyser (LORCA): I A new instrument for measurement of various hemorheological structural parameters, Clin. Hemorheol. 14 (1994), 605-618.
21. M.R. Hardeman, P.T. Goedhart and N.H. Schut, Laser-assist optical rotational cell analyser (LORCA): II Red blood cell deformability: Elongation index versus cell transit time, Clin. Hemorheol. 14 (1994), 619-630.
22. H. Schmid-Schonbein, G. Gallasch, E. Volger and H.J. Klose, Microrheology and protein chemistry of pathological red cell aggregation (blood sludge) studies in vitro, Biorheology 10 (1973), 213-227.
23. I. Cicha, Y. Suzuki, N. Tateishi and N. Maeda, Enhancement of red blood cell aggregation by plasma triglycerides, Clin. Hemorheol. Microcirc. 24 (2001), 247-255.
24. R. Ben Ami, G. Barshtein, D. Zeltser et al., Parameters of red blood cell aggregation as correlates of the inflammatory state, Am. J. Physiol. Heart. Circ. Physiol. 280 (2001), H1982-1988.
25. N. Maeda and T. Shiga, Opposite effect of albumin on the erythrocyte aggregation induced by immunoglobulin G and fibrinogen, Biochim. Biophys. Acta 855 (1986), 127-135.
26. C. Lacombe, C. Bucherer, J. Ladjouzi and J.C. Lelievre, Competitive role between fibrinogen and albumin on thixotropy of red cell suspensions, Biorheology 25 (1988), 349-354.
27. R. Ben-Ami, G. Barshtein, T. Mardi, V. Deutch, O. Elkayam, S. Yedgar and S. Berliner, A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation, Am. J. Physiol. Heart. Circ. Physiol. 285 (2003), H2663-2669.
28. M.V. Kameneva, J.F. Antaki, M.J. Watach, H.S. Borovetz and R.L. Kormos, Heparin effect on red blood cell aggregation, Biorheology 31 (1994), 297-304.
29. K.M. Taylor, SIRS - the systemic inflammatory response syndrome after cardiac operations, Ann. Thorac. Surg. 61 (1996), 1607-1608.
30. R.J. Powell, G.W. Machiedo, B.F. Rush Jr. and G. Dikdan, Oxygen free redicals: effect on red cell deformability in sepsis, Crit. Care. Med. 19 (1991), 732-735.
31. G. Cicco and A. Pirrelli, Red blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertension, Clin. Hemorheol. Microcirc. 21 (1999), 169-177.
32. O.K. Baskurt, D. Gelmont and H.J. Meiselman, Red blood cell deformability in sepsis, Am. J. Respir. Crit. Care. Med. 157 (1998), 421-427.
33. F. Jung, A. Seegert, H.G. Roggenkamp, C. Mrowietz, H.P. Nuttgens, H. Kiesewetter, H. Zeller and G. Muller, Gleichzeitige Erfassung von Hamatokrit, Erythrozytenaggregation und -desaggregation: Methodik, Qualitatskontrolle und Referenzbereich, Biomed. Tech. (Berl.) 32 (1987), 117-125.
34. M.W. Rampling, H.J. Meiselman, B. Neu and O.K. Baskurt, Influence of cell-specific factors on red blood cell aggregation, Biorheology 41 (2004), 91-112.